Comparisons › CVS / ELV
CVS Health vs Elevance Health: comparing CVS and ELV stock
12-month growth, from 100━ CVS +5.3% ━ ELV +37.4%
| Metric | CVS | ELV |
|---|---|---|
| Price, $ | 81.33 | 432.00 |
| Year to date | +4.2% | +24.0% ● |
| 12 months | +5.3% | +37.4% ● |
| From 52-week high | −26.5% | −4.1% ● |
| vs 200-day average | −8.3% | +15.8% ● |
| P/E | 9.8 | 14.2 |
| Dividend yield | 2.95% ● | 1.64% |
| Revenue growth, YoY | +6.4% ● | +3.6% |
| Operating income growth | +46.2% ● | −8.6% |
| Operating margin | 3.5% | 4.0% ● |
| Gross margin | 13.8% | 26.4% ● |
| Market cap | $104.0B | $93.3B |
| Next earnings | Feb 17, 2027 | Jan 27, 2027 |
● — whose figure is higher, not which is better. Data as of Nov 5, 2026.
Ratings and a detailed chart for each are in the terminal.
Open the terminalFAQ
Which is better to buy: CVS Health or Elevance Health?
We do not advise what to buy. By the numbers: Elevance Health rose more over the year (+37.4%); Elevance Health is closer to its 52-week high; Elevance Health has the higher operating margin; CVS Health is growing revenue faster; CVS Health has the lower P/E. How to weigh such signs is covered in «How to analyse a stock».
Can I buy both?
Yes. Many hold several companies in one industry to avoid depending on one. A broad index fund often already holds the largest US companies.
When do they report?
CVS Health — Feb 17, 2027; Elevance Health — Jan 27, 2027.